Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA
Status:
Terminated
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to test whether adding chemotherapy/cabazitaxel and
hormonal/androgen deprivation therapy before surgical removal of your prostate would improve
the outcome of salvage surgery for locally recurrent prostate cancer after the initial
primary radiation therapy.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute